IFF Launches DEB Platform in Large-Scale Home Care Applications

Introduction

IFF has announced the first large-scale commercial use of its Designed Enzymatic Biomaterials™ (DEB) platform in a new laundry detergent formulation. This innovation replaces non-biodegradable ingredients with biodegradable alternatives, enhancing fabric softness and cleaning performance.

Technology and Development

Developed by IFF’s Health & Biosciences unit, the DEB platform utilizes advanced bioscience to create unique polysaccharides from renewable plant sugar sources. These biomaterials are engineered to deliver specific performance attributes, offering a bio-based solution that enhances surface modification and supports anti-redeposition benefits.

Manufacturing and Expansion

IFF is scaling DEB production through its joint venture with Kemira, Alpha Bio. This venture will establish a dedicated manufacturing asset for DEB-based materials. Following validation at facilities in Finland, Alpha Bio aims to introduce DEB-based solutions to multiple market sectors starting in 2027.

Future Prospects

As the DEB platform evolves, IFF is focused on unlocking its full potential across various industries, including health, nutrition, beauty, and packaging. The company is exploring the sustainability and performance benefits DEB can offer beyond the initial laundry application.